Sweden phases out AstraZeneca's covid-19 vaccine

89 percent of the Swedish population above the age of 65 are fully vaccinated, meaning authorities in Sweden are phasing out the use of the AstraZeneca vaccine. In Stockholm, residents now have a choice of vaccines.

Photo: Dado Ruvic/REUTERS / X02714

The coronavirus vaccine produced by AstraZeneca is gradually being phased out in Sweden.

On Friday, the Swedish health authorities announced that 89 percent of people of above the age group 65, the main recipients of this vaccine in Sweden, are now fully vaccinated.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs